Advisory Services Network’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
3,869
-161
-4% -$59.7K 0.02% 821
2026
Q1
$1.18M Sell
4,030
-485
-11% -$159K 0.02% 849
2025
Q4
$1.58M Sell
4,515
-1,912
-30% -$646K 0.02% 700
2025
Q3
$2.08M Buy
6,427
+2,594
+68% +$807K 0.03% 571
2025
Q2
$1.09M Buy
3,833
+1,556
+68% +$626K 0.02% 792
2025
Q1
$990K Sell
2,277
-122
-5% -$49K 0.02% 766
2024
Q4
$885K Sell
2,399
-1,379
-37% -$577K 0.02% 793
2024
Q3
$2.05M Hold
3,778
0.04% 462
2024
Q2
$2.05M Sell
3,778
-711
-16% -$376K 0.04% 462
2024
Q1
$2.33M Sell
4,489
-87
-2% -$43.3K 0.05% 405
2023
Q4
$2.16M Sell
4,576
-774
-14% -$358K 0.05% 410
2023
Q3
$2.33M Sell
5,350
-203
-4% -$92.1K 0.06% 364
2023
Q2
$2.47M Sell
5,553
-251
-4% -$116K 0.07% 342
2023
Q1
$2.67M Buy
5,804
+451
+8% +$215K 0.07% 313
2022
Q4
$2.75M Buy
5,353
+425
+9% +$216K 0.08% 280
2022
Q3
$2.24M Buy
4,928
+88
+2% +$42.1K 0.08% 298
2022
Q2
$2.34M Buy
4,840
+30
+0.6% +$14.8K 0.08% 292
2022
Q1
$2.36M Buy
4,810
+481
+11% +$220K 0.07% 351
2021
Q4
$2.01M Sell
4,329
-156
-3% -$65.6K 0.06% 407
2021
Q3
$1.67M Buy
4,485
+113
+3% +$42.9K 0.05% 431
2021
Q2
$1.67M Buy
4,372
+565
+15% +$216K 0.05% 437
2021
Q1
$1.37M Buy
3,807
+86
+2% +$27.7K 0.05% 457
2020
Q4
$1.2M Sell
3,721
-311
-8% -$95.4K 0.05% 440
2020
Q3
$1.08M Sell
4,032
-34
-0.8% -$9.15K 0.05% 392
2020
Q2
$1.07M Sell
4,066
-195
-5% -$52K 0.06% 372
2020
Q1
$967K Buy
4,261
+1,092
+34% +$298K 0.06% 344
2019
Q4
$957K Sell
3,169
-2,219
-41% -$611K 0.05% 434
2019
Q3
$1.52M Hold
5,388
0.09% 287
2019
Q2
$1.52M Sell
5,388
-114
-2% -$31.1K 0.09% 287
2019
Q1
$1.58M Sell
5,502
-487
-8% -$141K 0.11% 246
2018
Q4
$1.57M Sell
5,989
-201
-3% -$55.3K 0.14% 197
2018
Q3
$1.7M Sell
6,190
-964
-13% -$250K 0.12% 223
2018
Q2
$1.77M Sell
7,154
-2,087
-23% -$483K 0.13% 205
2018
Q1
$2.03M Buy
9,241
+5,282
+133% +$1.24M 0.16% 159
2017
Q4
$891K Sell
3,959
-433
-10% -$92.2K 0.08% 333
2017
Q3
$834K Sell
4,392
-730
-14% -$139K 0.1% 269
2017
Q2
$964K Buy
5,122
+2,354
+85% +$423K 0.13% 226
2017
Q1
$458K Buy
+2,768
New +$440K 0.07% 369
2016
Q3
$277K Buy
2,208
+6
+0.3% +$775 0.05% 430
2016
Q2
$289K Sell
2,202
-5
-0.2% -$684 0.07% 374
2016
Q1
$307K Buy
2,207
+106
+5% +$14.2K 0.08% 301
2015
Q4
$293K Buy
2,101
+870
+71% +$120K 0.09% 268
2015
Q3
$172K Sell
1,231
-3,159
-72% -$475K 0.05% 301
2015
Q2
$722K Buy
4,390
+195
+5% +$31.2K 0.21% 107
2015
Q1
$652K Sell
4,195
-34
-0.8% -$4.84K 0.18% 127
2014
Q4
$580K Sell
4,229
-331
-7% -$40.9K 0.18% 121
2014
Q3
$546K Buy
4,560
+1,404
+44% +$161K 0.2% 124
2014
Q2
$340K Buy
+3,156
New +$325K 0.14% 170
2014
Q1
Sell
-83
Closed -$8K 369
2013
Q4
$8K Buy
+83
New +$7.38K ﹤0.01% 652

Other funds holding ELV

Advisory Services Network's ELV Position: Q2 2026 in Review

Advisory Services Network reduced its Elevance Health (ELV) stake by 4% in Q2 2026, selling an estimated $59.7K and leaving 3,869 shares worth $1.5M. The position accounts for 0.02% of the portfolio, ranked #821.

Advisory Services Network first reported a position in ELV in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.75M in Q4 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Advisory Services Network held 3,869 shares of Elevance Health worth $1.5M as of Q2 2026.
  • Advisory Services Network sold 161 Elevance Health shares in Q2 2026, an estimated $59.7K.
  • Elevance Health made up 0.02% of Advisory Services Network's portfolio in Q2 2026, its #821 holding.
  • Advisory Services Network first reported a position in Elevance Health in Q4 2013 and has held it in 49 quarters since.
  • Advisory Services Network's Elevance Health position peaked at $2.75M in Q4 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.